Edition:
United States

Exalenz Bioscience Ltd (EXEN.TA)

EXEN.TA on Tel Aviv Stock Exchange

540.00
18 Jan 2017
Change (% chg)

5.00₪ (+0.93%)
Prev Close
535.00₪
Open
535.10₪
Day's High
540.00₪
Day's Low
535.00₪
Volume
3,233
Avg. Vol
22,473
52-wk High
750.00₪
52-wk Low
187.60₪

EXEN.TA

Chart for EXEN.TA

About

Exalenz Bioscience Ltd is an Israel-based company active in the medical sector. It develops and commercializes advanced systems that extract vital information for diagnostics from subtle changes in the patient's exhaled breath. Its core technology enables medical specialists to identify and manage specific digestive and liver... (more)
No analyst recommendations are available for EXEN.TA.

Overall

Beta: 0.06
Market Cap(Mil.): ₪136.38
Shares Outstanding(Mil.): 25.49
Dividend: --
Yield (%): --

Financials

  EXEN.TA Industry Sector
P/E (TTM): -- 33.71 30.46
EPS (TTM): -1.74 -- --
ROI: -96.65 13.21 14.82
ROE: -785.80 16.83 16.24

BRIEF-Exalenz Bioscience receives fda marketing clearance for its laboratory system in the U.S.

* Exalenz Bioscience receives FDA marketing clearance for its laboratory system in the United States

Nov 01 2016

BRIEF-Exalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID to Monitor Patients with Cirrhosis Associated with NASH

* Exalenz Bioscience announces collaboration with Conatus Pharmaceuticals to use BreathID to monitor patients with cirrhosis associated with NASH

Aug 29 2016

Earnings vs. Estimates

No consensus analysis data available.